The role of b-blockers in treatment of hypertension, according to Russian and European experts | Zendy

О. Д. Остроумова | Zendy; В. М. Фомина | Zendy; G N Shchukina | Zendy; Е. А. Смолярчук | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The role of b-blockers in treatment of hypertension, according to Russian and European experts

Author(s) -

О. Д. Остроумова,

В. М. Фомина,

G N Shchukina,

Е. А. Смолярчук

Publication year - 2016

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg29112

Subject(s) - medicine , dyslipidemia , atrial fibrillation , cardiology , heart failure , metoprolol , diabetes mellitus , coronary artery disease , metabolic syndrome , disease , obesity , endocrinology

The article focuses on the use of b-blockers for the treatment of arterial hypertension (AH). Given the situation of modern Russian and European recommendations about the place of b-blockers in the treatment of AH, including their benefits with a combination of hypertension with coronary heart disease, chronic heart failure, atrial fibrillation. Analyzed the efficacy and safety of b-blockers in diabetes mellitus, metabolic syndrome, dyslipidemia, peripheral artery, chronic obstructive pulmonary disease, sexual dysfunction, in individuals of different age and gender. It is emphasized that the selection of b-blockers inside of a class is determined by its selectivity, the study in clinical studies, pharmacokinetic characteristics. Data about efficiency and safety of application of metoprolol succinate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research